Starch microparticles as a vaccine adjuvant: Only uptake in Peyer's patches decides the profile of the immune response

Vaccine

Volumn 24, Issue 17, 2006, Pages 3661-3668

  Stertman, Linda ^a   Lundgren, Ebba ^a   Sjöholm, Ingvar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Mucosal immune response; Oral immunisation; Parenteral immunisation; rCTB; Starch microparticles; Th1 Th2 differentiation; Vaccine

Indexed keywords

CHOLERA TOXIN B SUBUNIT; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; STARCH;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; CHOLERA TOXIN; FEMALE; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; SERUM ALBUMIN; STARCH; VACCINES;

EID: 33645237550     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.059     Document Type: Article

References (35)

1. D. Grdic, R. Smith, A. Donachie, M. Kjerrulf, E. Hörnquist, and A. Mowat The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action Eur J Immunol 29 6 1999 1774 1784
2. S.J. McKenzie, and J.F. Halsey Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response J Immunol 133 4 1984 1818 1824
3. C. Czerkinsky, M.W. Russell, N. Lycke, M. Lindblad, and J. Holmgren Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues Infect Immun 57 4 1989 1072 1077
4. C. Rask, M. Fredriksson, M. Lindblad, C. Czerkinsky, and J. Holmgren Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant APMIS 108 3 2000 178 186
5. T.G. Kim, N. Befus, and W.H. Langridge Co-immunization with an HIV-1 Tat transduction peptide-rotavirus enterotoxin fusion protein stimulates a Th1 mucosal immune response in mice Vaccine 22 3-4 2004 431 438
6. R. Rappuoli, M. Pizza, G. Douce, and G. Dougan Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins Immunol Today 20 11 1999 493 500
7. M.L. Francis, J. Ryan, M.G. Jobling, R.K. Holmes, J. Moss, and J.J. Mond Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation J Immunol 148 7 1992 1999 2005
8. T.O. Nashar, N.A. Williams, T.R. Hirst, and T.O. Nahar Cross-linking of cell surface ganglioside GM1 induces the selective apoptosis of mature CD8 + T lymphocytes Int Immunol 8 5 1996 731 736
9. A. George-Chandy, K. Eriksson, M. Lebens, I. Nordström, E. Schon, and J. Holmgren Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells Infect Immun 69 9 2001 5716 5725
10. K. Eriksson, M. Fredriksson, I. Nordström, and J. Holmgren Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development Infect Immun 71 4 2003 1740 1747
11. N.A. Williams, T.R. Hirst, and T.O. Nashar Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic Immunol Today 20 2 1999 95 101
12. L. Wikingsson, and I. Sjöholm Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice Vaccine 20 27-28 2002 3355 3363
13. L. Strindelius, M. Filler, and I. Sjöholm Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice Vaccine 22 27-28 2004 3797 3808
14. N. Rydell, and I. Sjöholm Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant Vaccine 22 9-10 2004 1265 1274
15. N. Rydell, L. Stertman, and I. Sjöholm Starch microparticles as vaccine adjuvant Expert Opin Drug Deliv 2 5 2005 807 828
16. A. Larhed, L. Stertman, E. Edvardsson, and I. Sjöholm Starch microparticles as oral vaccine adjuvant: antigen-dependent uptake in mouse intestinal mucosa J Drug Target 12 5 2004 289 296
17. B.L. Kelsall, and W. Strober Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch J Exp Med 183 1 1996 237 247
18. A. Iwasaki, and B.L. Kelsall Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine J Exp Med 191 8 2000 1381 1394
19. A. Iwasaki, and B.L. Kelsall Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells J Immunol 166 8 2001 4884 4890
20. P. Artursson, P. Edman, T. Laakso, and I. Sjöholm Characterization of polyacryl starch microparticles as carriers for proteins and drugs J Pharm Sci 73 11 1984 1507 1513
21. T. Laakso, P. Artursson, and I. Sjöholm Biodegradable microspheres. IV: factors affecting the distribution and degradation of polyacryl starch microparticles J Pharm Sci 75 10 1986 962 967
22. G.S. Bethell, J.S. Ayers, W.S. Hancock, and M.T. Hearn A novel method of activation of cross-linked agaroses with 1,1′-carbonyldiimidazole which gives a matrix for affinity chromatography devoid of additional charged groups J Biol Chem 254 8 1979 2572 2574
23. L. Stertman, L. Strindelius, and I. Sjöholm Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice Vaccine 22 21-22 2004 2863 2872
24. A.J. Macpherson, and T. Uhr Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria Science 303 5664 2004 1662 1665
25. C. Nagler-Anderson, C. Terhoust, A.K. Bhan, and D.K. Podolsky Mucosal antigen presentation and the control of tolerance and immunity Trends Immunol 22 3 2001 120 122
26. R.M. Hershberg, D.H. Cho, A. Youakim, M.B. Bradley, J.S. Lee, and P.E. Framson Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells J Clin Invest 102 4 1998 792 803
27. R.M. Hershberg, P.E. Framson, D.H. Cho, L.Y. Lee, S. Kovats, and J. Beitz Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing J Clin Invest 100 1 1997 204 215
28. I.R. Sanderson, A.J. Ouellette, E.A. Carter, W.A. Walker, and P.R. Harmatz Differential regulation of B7 mRNA in enterocytes and lymphoid cells Immunology 79 3 1993 434 438
29. U.Y. Khoo, I.E. Proctor, and A.J. Macpherson CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens J Immunol 158 8 1997 3626 3634
30. L. Lazorova, A. Sjölander, G.J. Russell-Jones, J. Linder, and P. Artursson Intestinal tissue distribution and epithelial transport of the oral immunogen LTB, the B subunit of E. coli heat-labile enterotoxin J Drug Target 1 4 1993 331 340
31. A.T. Aman, S. Fraser, E.A. Merritt, C. Rodigherio, M. Kenny, and M. Ahn A mutant cholera toxin B subunit that binds GM1-ganglioside but lacks immunomodulatory or toxic activity Proc Natl Acad Sci USA 98 15 2001 8536 8541
32. S.A. Fraser, L. de Haan, A.R. Hearn, H.K. Bone, R.J. Salmond, and A.J. Rivett Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions Infect Immun 71 3 2003 1527 1537
33. M. Marinaro, H.F. Staats, T. Hiroi, R.J. Jackson, M. Coste, and P.N. Boyaka Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4 J Immunol 155 10 1995 4621 4629
34. J. Ekström, K.F. Hu, K.L. Bengtsson, and B. Morein Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions Vaccine 17 20-21 1999 2690 2701
35. M. Isaka, Y. Yasuda, M. Mizokami, S. Kozuka, T. Taniguchi, and K. Matano Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant Vaccine 19 11-12 2001 1460 1466